Proteins having a TNF action comprising TNF-fibromectin fusion protein

US5180811A · kind A · utility

Assignee

• BASF SE

Inventors

• Thomas Doerper · Bissersheim, DE
• Achim Moeller · Grünstadt, DE
• Heinz Hillen · Herbrechtingen, DE
• Gerhard Keilhauer · Marlboro, US
• Franz Emling · Ludwigshafen, DE
• Lothar Daum · Otterstadt, DE

Key dates

• Filing date: May 13, 1988
• Grant date: Jan 19, 1993
• Expiry date: May 13, 2008

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S930/144
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Derivatives of a tumor necrosis factor (TNF), which originate from a modification at the amino terminus of the TNF molecule are suitable for controlling diseases.